副研究员

张绪，博士，深圳大学副研究员。

Email: zhangxu88@szu.edu.cn

博士毕业于香港城市大学。

科研能力及成果

代表性论著：

(1) Zhang X, Asim M, Fang W, et al. Cholecystokinin B receptor antagonists for the treatment of depression via blocking long-term potentiation in the basolateral amygdala[J]. Molecular Psychiatry, 2023: 1-16. (期刊论文)

(2) Chen, X., Li, X., Wong, Y. T., Zheng, X., Wang, H., Peng, Y., Zhang, x... & He, J. (2019). Cholecystokinin release triggered by NMDA receptors produces LTP and sound–sound associative memory. Proceedings of the National Academy of Sciences, 116(13), 6397-6406. (期刊论文)

(3) Nan Zhang, Yixuan Sui, Peter Jendrichovsky, Hemin Feng, Heng Shi, Xu Zhang, Shenghui Xu, Wenjian Sun, Huatang Zhang, Micky Tortorella, Xi Chen, and Jufang He,Cholecystokinin B Receptor Agonists Alleviates Anterograde Amnesia in Aged Alzheimer's Disease Mice, NCOMMS-23-04057-T, Nature Communications. (期刊论文)

(4) Ying Xu, Chi Zhang, Baobao Pan, Qing Yuan, Xu Zhang（corresponding author）, Application of VR eye movement cognitive assessment in the early screening of cognitive impairment, Frontiers in Medicine, section Geriatric Medicine under review，Research Square, 2023 https://doi.org/10.21203/rs.3.rs-2825752/v1

(5) Xueqiang Zhao, Xiaoqing Wu, Chi Zhang, Xu Zhang (corresponding author) Application of VR Head-Mounted Display Training System in Quantitative Evaluation of Trunk Control and Balance Function, Research Square, 2023 https://assets.researchsquare.com/files/rs-2935534/v1/cb3a926d-0582-4289-b4a5-d9beba1e9d2d.pdf?c=1684269492

(6) 《运动控制：将科研转化为临床实践》副主译（著作）

(7) 《肩关节复合体：评估、治疗与康复》副主译（著作）

(8) 《临床康复一体化-ERAS探索》编者（著作）

论著之外的代表性研究成果和学术奖励：

(1) Method And Composition for Treating Epilepsy, HE, J., LI, X., TAN, A., XU, S., PENG, Y., YANG, Y., ZHANG, X. & HOSSAIN, M. M., 5 Jan 2021, Patent No.US10,881,667. Priority No. 16/174,842 (专利)

(2) Method and Composition for Treating Mental Disorder and Pain Associated with NerveDamage，HE, J., ZHANG, X., XU, S., FENG, H., HAU, S. & ZHANG, G., 26 Apr 2019, (Accepted/In press/Filed) Priority No. 16/395,499(专利)

(3) Method and composition for treating epilepsy，HE, J., LI, X., TAN, A., XU, S., PENG, Y., YANG, Y., ZHANG, X. & HOSSAIN, M. M., 16 Oct 2019, (Accepted/Inpress/Filed) Priority No. PCT/CN2019/111446(专利)

(4) Method And Composition for Treating Mental Disorder And Pain Associated with Nerve Damage，HE, J., ZHANG, X., XU, S., FENG, H., HAU, S. & ZHANG, C., 26 Apr 2019, (Accepted/In press/Filed) Priority No. 202010341297.3(专利)

(5) 基于VR眼动追踪的痴呆风险筛查系统、设备及介质，发明专利， CN 114724709 B ，2022.10.14，王思伦，张绪

(6) 具有量化评估功能的VR康复训练方法及系统，发明专利，CN115862810A，2023-03-28，王思伦、张绪、张弛

代表性成果转化：

(1) VR眼动认知评估与康复系统，二类医疗器械证书，落地20余家机构及项目，如深圳市失能失智筛查项目

项目情况

(1) 香港创新及科技基金项目，”胆囊收缩素受体拮抗剂治疗老年抑郁症特别是慢性痛并发抑郁症”, 2020-2022, 500m HKD, 主要研究员, 参加

(2) 香港健康及医学研究基金项目，“应用小鼠抑郁模型，研究胆囊收缩素受体拮抗剂治疗抑郁症的机制” 2022-2025，150m HKD，主要研究员，参与

(3) 深圳市自然科学基金，VR眼动追踪认知功能评估与AD的早期筛查的应用研究，2022-2025，主要研究员，参与

(4) 2023年度可持续发展科技专项,VR数字疗法在围产期管理中的应用研究,主要研究员，参与